Wefunder logo

Stapgen LLC

We aim to prevent T2DM prior to the rise of blood sugar.

Last Funded March 2023

$62,686

raised from 54 investors

Highlights

1
Patented STAP-Test may detect and provide risk of developing Type 2 Diabetes 5 years in advance
2
Few other companies in USA can detect and intercept developing T2DM prior to the rise of blood sugar
3
Dr. MS Malo dedicated over 40 years in the field of Medicine and Biotech and have 7 patents
4
6.7 million death attributed to diabetes world-wide in 2021 according to IDF

Featured Investor

Our Team

We believe that this will be the single most important diagnostic test in preventive care to detect overall health status and bring down the cost of health care significantly lower.

Pitch

Stapgen LLC holds the license to the patent of STAP-Test, owned by Dr. Madhu Malo and his company Atoxin Biotech

Stapgen LLC holds the license to the patent of STAP-Test, owned by Dr. Madhu Malo and his company Atoxin Biotech

Stapgen LLC holds the license to the patent of STAP-Test, owned by Dr. Madhu Malo and his company Atoxin Biotech

Downloads

Overview